Literature DB >> 11503765

Opioid drugs in maintenance and detoxification treatment of opiate addiction; Substance Abuse and Mental Health Services Administration, HHS. Final rule.

.   

Abstract

The Department of Health and Human Services and the Substance Abuse and Mental Health Services Administration (SAMHSA) are issuing final regulations for the use of narcotic drugs in maintenance and detoxification treatment of opioid addiction. This final rule repeals the existing narcotic treatment regulations enforced by the Food and Drug Administration (FDA), and creates a new regulatory system based on an accreditation model. In addition, this final rule shifts administrative responsibility and oversight from FDA to SAMHSA. This rulemaking initiative follows a study by the Institute of Medicine (IOM) and reflects recommendations by the IOM and several other entities to improve opioid addiction treatment by allowing for increased medical judgment in treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11503765

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  10 in total

1.  Policy progress for physician treatment of opiate addiction.

Authors:  Joseph O Merrill
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Beliefs about methadone in an inner-city methadone clinic.

Authors:  Sharon Stancliff; Julie Elana Myers; Stuart Steiner; Ernest Drucker
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

3.  New Federal Regulations for Improving Quality in Opioid Treatment Programs.

Authors:  Luc R Pelletier; Jeffrey A Hoffman
Journal:  J Healthc Qual       Date:  2001       Impact factor: 1.095

Review 4.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

5.  Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.

Authors:  L J Cohen; E Gertmenian-King; L Kunik; C Weaver; E D London; I Galynker
Journal:  Acta Psychiatr Scand       Date:  2005-08       Impact factor: 6.392

6.  Methadone medical maintenance in primary care. An implementation evaluation.

Authors:  Joseph O Merrill; T Ron Jackson; Beryl A Schulman; Andrew J Saxon; Asaad Awan; Sonja Kapitan; Molly Carney; Lyndia C Brumback; Dennis Donovan
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

Review 7.  Treatment of heroin (diamorphine) addiction: current approaches and future prospects.

Authors:  Gerardo Gonzalez; Alison Oliveto; Thomas R Kosten
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.

Authors:  D Andrew Tompkins; George E Bigelow; Joseph A Harrison; Rolley E Johnson; Paul J Fudala; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2009-08-03       Impact factor: 4.492

9.  Treatment practice and research issues in improving opioid treatment outcomes.

Authors:  T Ron Jackson
Journal:  Sci Pract Perspect       Date:  2002-07

10.  Character pathology and neuropsychological test performance in remitted opiate dependence.

Authors:  James M Prosser; Daniel Eisenberg; Emily E Davey; Matthew Steinfeld; Lisa J Cohen; Edythe D London; Igor I Galynker
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.